pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant

摘要

Background: Phosphohistone-H3 (pHH3) is a promising reliable mitotic count biomarker. Our purpose was to study the relationship between the novel proliferation marker pHH3 and the established anti-apoptotic marker survivin and consider their prognostic relevance in endometrial cancer.